Literature DB >> 11517849

Pain, mood disturbance, and quality of life in patients with multiple myeloma.

A R Poulos1, M A Gertz, V S Pankratz, J Post-White.   

Abstract

PURPOSE/
OBJECTIVES: To determine the levels of pain intensity and pain interference in patients with multiple myeloma, the relationship between pain and mood disturbance, and factors that influence quality of life (QOL).
DESIGN: Descriptive correlational mailed survey.
SETTING: A private tertiary institution in the Midwest. SAMPLE: Convenience sample of 346 adult patients with multiple myeloma identified through an institutional database, 206 of whom responded to the surveys.
METHODS: Mailed, self-administered questionnaires: Brief Pain Inventory Short Form, Profile of Mood States, QOL Scale (Cancer Patient Version), and a demographic tool. Treatment details were obtained from the database on subjects consenting to participate. MAIN RESEARCH VARIABLES: Pain intensity, pain interference, psychologic functioning, and QOL.
FINDINGS: 29% (n = 60) of subjects reported moderate to severe pain intensity. Significant associations were found between pain intensity and mood disturbance scores. As pain interference increased, so did levels of mood disturbance. A joint predictive model explained 74.6% of the variability in total QOL scores.
CONCLUSIONS: Cancer pain remains undertreated, and patients with myeloma are no exception. Pain and mood disturbance scores were significant predictors of QOL in this group of patients. Subjects with multiple myeloma reported higher levels of mood disturbance than patients with cancer from other studies. IMPLICATIONS FOR NURSING PRACTICE: The oncology nurse is in a key position to facilitate ongoing, adequate pain and psychosocial assessment of patients with myeloma. Further study is needed to determine if control of pain and mood disturbance factors has a positive effect on the various domains of QOL.

Entities:  

Mesh:

Year:  2001        PMID: 11517849

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  14 in total

1.  Towards a better understanding of the relationship between side effects of analgesia and quality of life in patients with multiple myeloma.

Authors:  Pasquale Niscola; Agostina Siniscalchi; Andrea Tendas; Paolo de Fabritiis; Tommaso Caravita; Fabio Efficace
Journal:  Support Care Cancer       Date:  2015-08-04       Impact factor: 3.603

2.  Gender and ethnic differences in cancer pain experience: a multiethnic survey in the United States.

Authors:  Eun-Ok Im; Wonshik Chee; Enrique Guevara; Yi Liu; Hyun-Ju Lim; Hsiu-Min Tsai; Maresha Clark; Melinda Bender; Kyung Suk Kim; Young Hee Kim; Hyunjeong Shin
Journal:  Nurs Res       Date:  2007 Sep-Oct       Impact factor: 2.381

3.  Bone Pain Induced by Multiple Myeloma Is Reduced by Targeting V-ATPase and ASIC3.

Authors:  Masahiro Hiasa; Tatsuo Okui; Yohance M Allette; Matthew S Ripsch; Ge-Hong Sun-Wada; Hiroki Wakabayashi; G David Roodman; Fletcher A White; Toshiyuki Yoneda
Journal:  Cancer Res       Date:  2017-03-02       Impact factor: 12.701

4.  Fatigue, sleep, pain, mood, and performance status in patients with multiple myeloma.

Authors:  Elizabeth Ann Coleman; Julia A Goodwin; Sharon K Coon; Kathy Richards; Carol Enderlin; Robert Kennedy; Carol B Stewart; Paula McNatt; Kim Lockhart; Elias J Anaissie; Bart Barlogie
Journal:  Cancer Nurs       Date:  2011 May-Jun       Impact factor: 2.592

5.  Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.

Authors:  Michel Delforge; Leonard Minuk; Jean-Claude Eisenmann; Bertrand Arnulf; Letizia Canepa; Alberto Fragasso; Serge Leyvraz; Christian Langer; Yousef Ezaydi; Dan T Vogl; Pilar Giraldo-Castellano; Sung-Soo Yoon; Charles Zarnitsky; Martine Escoffre-Barbe; Bernard Lemieux; Kevin Song; Nizar Jacques Bahlis; Shien Guo; Mara Silva Monzini; Annette Ervin-Haynes; Vanessa Houck; Thierry Facon
Journal:  Haematologica       Date:  2015-03-13       Impact factor: 9.941

6.  Content development for the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale construction.

Authors:  Lynne I Wagner; Don Robinson; Matthias Weiss; Michael Katz; Phillip Greipp; Rafael Fonseca; David Cella
Journal:  J Pain Symptom Manage       Date:  2012-05-09       Impact factor: 3.612

7.  The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation.

Authors:  Madeline L O'Sullivan; Rebecca A Shelby; Caroline S Dorfman; Sarah A Kelleher; Hannah M Fisher; Krista A Rowe Nichols; Francis J Keefe; Anthony D Sung; Tamara J Somers
Journal:  Support Care Cancer       Date:  2017-11-09       Impact factor: 3.359

8.  Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study.

Authors:  Karin Jordan; Irina Proskorovsky; Philip Lewis; Jack Ishak; Krista Payne; Noreen Lordan; Charalampia Kyriakou; Cathy D Williams; Sarah Peters; Faith E Davies
Journal:  Support Care Cancer       Date:  2014-02       Impact factor: 3.603

9.  A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors.

Authors:  Lara Groeneveldt; Gill Mein; Rachel Garrod; Andrew P Jewell; Ken Van Someren; Richard Stephens; Shirley P D'Sa; Kwee L Yong
Journal:  BMC Cancer       Date:  2013-01-24       Impact factor: 4.430

10.  Symptom clusters among multiethnic groups of cancer patients with pain.

Authors:  Eun-Ok Im; Young Ko; Wonshik Chee
Journal:  Palliat Support Care       Date:  2012-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.